Senate bill · S. 4494 (119th Congress)
American Cures Act
U.S. Senate
Summary
American Cures Act This bill permanently funds several federal agencies and programs that perform biomedical research. The bill provides specified funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense health program, and the Department of Veterans Affairs medical and prosthetics research program. The bill exempts the funding from sequestration, which is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals. It also exempts the budgetary effects of the funding from the Statutory Pay-As-You-Go (PAYGO) Act of 2010 and the Senate PAYGO rule.
Summary from the Congressional Research Service. How we handle summaries
From Congress.gov and official rosters. This record was last updated Aug 1, 2026. About our data
Following needs an Agora account. You will sign in first, then come back to this page.
Your position on this bill
Choose the position closest to yours. You'll sign in or create an account to save it.
Where it stands
Assigned to a committee for review.
- Introduced
- In committee
- Up for a vote
- Passed one chamber
- Passed
- Enacted
Committee
House Committee on Appropriations · U.S. House of Representatives
Also referred to Senate Committee on Appropriations · U.S. Senate.
Cosponsors
Chris Van Hollen, Richard Blumenthal and 1 other
Cosponsors listed on Congress.gov, shown A to Z.
- Democratic3
Shown in neutral colors by design; Agora is non-partisan.
Full history
- May 12, 2026
Introduced
Introduced in U.S. Senate
U.S. Senate
- May 12, 2026
Referred to committee
Read twice and referred to the Committee on Appropriations. (text: CR S2239)
- May 12, 2026
Referred to committee
Read twice and referred to the Committee on Appropriations. (text: CR S2239)
- May 12, 2026
Referred to committee
Read twice and referred to the Committee on Appropriations. (text: CR S2239)